Photochemotherapy of Infrared Active BODIPY-Appended Iron(III) Catecholates for in Vivo Tumor Growth Inhibition

Iron(III) catecholates of BODIPY (boron-dipyrromethene)-conjugated dipicolylamine ligands, viz. [Fe(L1)(cat)Cl] (1) and [Fe(L2)(cat)Cl] (2) (H2cat = catechol), with a ligand-to-metal charge transfer band at ∼800 nm were studied for their in vivo activity in dark and infrared light in luciferase-expressing human breast adenocarcinoma (BT474luc) cells. Complex 2 displayed in vitro photocytotoxicity in BT474luc cells (IC50: 6 μM) in infrared light of 600–720 nm with moderate dark toxicity (IC50: 18 μM) as evidenced from the MTT and Annexin-V FITC/PI staining assays. The mitochondria-localizing complexes showed apoptotic cell death involving reactive oxygen species whose generation was evidenced from 2,7-dichlorofluorescein diacetate assay. In vivo studies showed tumor growth inhibition in mice with an optimized complex 2 dose of 5 mg per kg body weight on exposure to infrared light of 685 nm (dose of 20 mW/cm2). The in vivo results exemplify complex 2 as a unique iron-based infrared-active photochemotherapeutic agent.

[1]  P. Kondaiah,et al.  Glucose-Appended Platinum(II)-BODIPY Conjugates for Targeted Photodynamic Therapy in Red Light. , 2018, Inorganic chemistry.

[2]  Arnab Bhattacharyya,et al.  Mitochondria‐Targeted Anticancer Activity of BODIPY‐Appended Iron(III) Catecholates in Red Light , 2017 .

[3]  Saran Long,et al.  A lysosome-targeted BODIPY as potential NIR photosensitizer for photodynamic therapy , 2017 .

[4]  P. Qin,et al.  A Platinum(II)-based Photosensitive Tripod as an Effective Photodynamic Anticancer Agent through DNA Damage. , 2017, Chemistry.

[5]  Arnab Bhattacharyya,et al.  Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity. , 2017, Inorganic chemistry.

[6]  P. Kondaiah,et al.  Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity. , 2017, Inorganic chemistry.

[7]  P. Sadler,et al.  Advances in the design of organometallic anticancer complexes , 2017 .

[8]  Zhigang Xie,et al.  Near infrared BODIPY-Platinum conjugates for imaging, photodynamic therapy and chemotherapy , 2017 .

[9]  Mafalda Laranjo,et al.  Platinum(II) Ring-Fused Chlorins as Near-Infrared Emitting Oxygen Sensors and Photodynamic Agents. , 2017, ACS medicinal chemistry letters.

[10]  C. Buske,et al.  Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications , 2017, Journal of the American Chemical Society.

[11]  Tianfeng Chen,et al.  Anticancer and Antiangiogenic Iron(II) Complexes That Target Thioredoxin Reductase to Trigger Cancer Cell Apoptosis. , 2017, Journal of medicinal chemistry.

[12]  Yuliang Zhao,et al.  Bifunctional Platinated Nanoparticles for Photoinduced Tumor Ablation , 2016, Advanced materials.

[13]  P. Kondaiah,et al.  Photoactive platinum(ii) β-diketonates as dual action anticancer agents. , 2016, Dalton transactions.

[14]  P. Kondaiah,et al.  Photorelease and Cellular Delivery of Mitocurcumin from Its Cytotoxic Cobalt(III) Complex in Visible Light. , 2016, Inorganic chemistry.

[15]  R. Hoffman.  Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts , 2015, Nature Reviews Cancer.

[16]  Zong-ping Wang,et al.  Catechin as a new improving agent for a photo-Fenton-like system at near-neutral pH for the removal of inderal , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[17]  S. Ferrari,et al.  Combination of Ru(ii) complexes and light: new frontiers in cancer therapy , 2015, Chemical science.

[18]  P. Kondaiah,et al.  Iron(III) catecholates for cellular imaging and photocytotoxicity in red light. , 2014, Chemistry, an Asian journal.

[19]  S. Dhar,et al.  Detouring of cisplatin to access mitochondrial genome for overcoming resistance , 2014, Proceedings of the National Academy of Sciences.

[20]  P. Kondaiah,et al.  Carbohydrate-appended tumor targeting iron(III) complexes showing photocytotoxicity in red light. , 2014, Inorganic chemistry.

[21]  K. Burgess,et al.  BODIPY dyes in photodynamic therapy. , 2013, Chemical Society reviews.

[22]  Shahram Hejazi,et al.  Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers. , 2012, Chemistry of materials : a publication of the American Chemical Society.

[23]  Zhen Yu,et al.  In vitro and in vivo fluorescent imaging of a monofunctional chelated platinum complex excitable using visible light. , 2011, Inorganic chemistry.

[24]  Di Chen,et al.  Novel metals and metal complexes as platforms for cancer therapy. , 2010, Current pharmaceutical design.

[25]  Gang Zheng,et al.  Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.

[26]  G. Roelfes,et al.  Double strand DNA cleavage with a binuclear iron complex. , 2007, Chemical communications.

[27]  S. Dhar,et al.  Ternary iron(II) complex with an emissive imidazopyridine arm from Schiff base cyclizations and its oxidative DNA cleavage activity. , 2005, Dalton transactions.

[28]  C. Che,et al.  Highly cytotoxic iron(II) complexes with pentadentate pyridyl ligands as a new class of anti-tumor agents. , 2005, Chemical communications.

[29]  S. Eksborg,et al.  Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig , 2000, Hearing Research.

[30]  C. Giandomenico,et al.  Current status of platinum-based antitumor drugs. , 1999, Chemical reviews.

[31]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[32]  R. Burger.  Cleavage of Nucleic Acids by Bleomycin. , 1998, Chemical reviews.

[33]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[34]  R. Hoffman.  Patient-Derived Mouse Models of Cancer , 2017, Molecular and Translational Medicine.

[35]  Robert M. Hoffman,et al.  Orthotopic Metastatic Mouse Models for Anticancer Drug Discovery and Evaluation: a Bridge to the Clinic , 2004, Investigational New Drugs.

[36]  R. Hertzberg,et al.  Cleavage of double helical DNA by methidium-propyl-EDTA-iron(II) , 1982 .

[37]  J. Harrington,et al.  Platinum nephrotoxicity. , 1978, The American journal of medicine.